Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vascular Smooth Muscle as a Target for Novel Therapeutics.

Current diabetes reports - 1 Oct 2015

Porter Karen E, Riches Kirsten

Abstract excerpt

Cardiovascular disease is the principal cause of death in patients with type 2 diabetes (T2DM). Exposure of the vasculature to metabolic disturbances leaves a persistent imprint on vascular walls, and specifically on smooth muscle cells (SMC) that favours their dysfunction and potentially underlies macrovascular complications of T2DM. Current diabetes therapies and continued development of newer treatments has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Diabetes Mellitus, Type 2
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MicroRNAs

Share to Muscle, Smooth, Vascular

Share to Phenotype

Source

Identifiers

PMID: 26277484
DOI: 10.1007/s11892-015-0647-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vascular Smooth Muscle as a Target for Novel Therapeutics.PMID 26277484Read ↗

Epigenetic Changes in Diabetes and Cardiovascular RiskSemantic proximity Read ↗

Identifying and targeting the molecular signature of smooth muscle cells undergoing early vascular ageingSemantic proximity Read ↗

Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?Semantic proximity Read ↗

Epigenetic Signatures in Arterial Hypertension: Focus on the MicrovasculatureSemantic proximity Read ↗

Role and mechanisms of vascular smooth muscle cell phenotypic transition in diabetic macrovascular complications.Semantic proximity Read ↗

Epigenetic mechanisms in cardiovascular complications of diabetes: towards future therapiesSemantic proximity Read ↗

Smooth muscle cell and arterial aging: basic and clinical aspects.Semantic proximity Read ↗

Transcriptomics analysis of long non-coding RNAs in smooth muscle cells from patients with peripheral artery disease and diabetes mellitusSemantic proximity Read ↗

Epigenetic basis of diabetic vasculopathySemantic proximity Read ↗

Epigenetics in Vascular Disease – Therapeutic Potential of New AgentsSemantic proximity Read ↗

Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic FrontiersSemantic proximity Read ↗

Vascular smooth muscle contraction in hypertension.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.